Lexaria Bioscience Corp.
LEXX · Pharmaceutical Preparations
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Bunka Christopher: Form 4
Insider disclosure · Filed · Report period 17 Mar 2026
-
Form 4
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-K
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001348362 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- LEXX on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 100 740 Mccurdy Road, Kelowna, British Columbia, Canada, V1X 2P7
- Incorporated in
- NV
- Fiscal year end
- 31 August
- Former names on EDGAR
- Lexaria Corp. (to 11 May 2016), LEXARIA CORP. (to 11 May 2016)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields